Partnerships
Partnerships with rare-disease federations and universities
DataLaps is a platform where physicians with verified identity and credentials validate clinical cases and distill conclusions through double-blind consensus. We seek to ally that capability with those who live close to rare diseases and with those who train the next generation of physicians. This page explains what the partnership program is, what we offer, and what we seek. It is an open program: it describes what we can already do today, without presenting as closed partnerships that do not yet exist.
What DataLaps offers
• Clinical cases validated by consensus among verified physicians (identity and credentials verified in three layers), with measurable agreement. • Training and a professional community for the physicians in your organization or faculty. • Visibility: verifiable public profiles for participating physicians and recognition of their contribution. • A transparent, traceable method: every public synthesis carries the signature of a human medical reviewer and discloses the use of AI (see our editorial policy).
What DataLaps seeks
• Spreading the mission among professionals and patient communities, so more physicians validate knowledge. • Real anonymized cases of rare conditions, where evidence is more scattered and consensus matters more. • Links and references from authority sites (federations, faculties, scientific societies) that recognize the joint work.
Rare-disease federations
In rare conditions, information is fragmented and few cases are published openly. DataLaps' consensus engine — several verified physicians issuing independent verdicts — can help distill and structure that knowledge responsibly. A partnership aligns directly with our mission: democratizing medical knowledge and putting it at the service of those who need it most.
Faculties and scientific societies
For universities and medical schools, DataLaps is an environment where students and residents can observe how clinical consensus is built among verified professionals, and where faculty can contribute and review cases. We seek honest academic collaborations, without exclusivity or commitments we cannot sustain today.
How to get started
A partnership starts with a conversation. Tell us who you are, whom you represent, and what you would like to build. We do not promise what we cannot deliver: every collaboration is defined explicitly and in writing before it is announced.
Let's talk about a partnership
If you represent a rare-disease federation, a medical school, or a scientific society, write to us. We review every request personally.
Frequently asked questions
Does DataLaps already have signed partnerships with federations?
The partnership program is open and under construction. We do not present as closed partnerships that do not yet exist: we describe what the platform can already offer today and discuss each collaboration explicitly.
What does my organization gain by partnering with DataLaps?
Access to cases validated by consensus among verified physicians, training and community for your professionals, verifiable public visibility for participants, and a transparent method with traceable authorship.
Is the clinical content reliable?
Every public synthesis passes a review gate: a human physician signs it, we confirm it contains no patient data, and any use of AI is disclosed. Without that signature, it is not published or indexed.
How is patient privacy protected?
We only work with anonymized cases and apply screening for identifiable data before publishing anything. Data protection is a prerequisite, not an add-on.
DataLaps content is educational and peer-to-peer; it is not clinical guidance, a diagnosis, nor a substitute for a treating physician's judgment. This partnership program is an open invitation to collaborate; it does not describe agreements already closed unless expressly stated.